FI63778B - FOERFARANDE FOER ISOLERING AV KLAMYDIA - Google Patents

FOERFARANDE FOER ISOLERING AV KLAMYDIA Download PDF

Info

Publication number
FI63778B
FI63778B FI814023A FI814023A FI63778B FI 63778 B FI63778 B FI 63778B FI 814023 A FI814023 A FI 814023A FI 814023 A FI814023 A FI 814023A FI 63778 B FI63778 B FI 63778B
Authority
FI
Finland
Prior art keywords
cells
cell
mmc
mccoy
chlamydia
Prior art date
Application number
FI814023A
Other languages
Finnish (fi)
Other versions
FI63778C (en
Inventor
Jorma Keski-Oja
Paul Partanen
Osmo Suovaniemi
Original Assignee
Labsystems Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Labsystems Oy filed Critical Labsystems Oy
Priority to FI814023A priority Critical patent/FI63778C/en
Priority to JP83500105A priority patent/JPS58502083A/en
Priority to PCT/FI1982/000063 priority patent/WO1983002122A1/en
Priority to EP19830900038 priority patent/EP0097196A1/en
Application granted granted Critical
Publication of FI63778B publication Critical patent/FI63778B/en
Publication of FI63778C publication Critical patent/FI63778C/en
Priority to SU833637905A priority patent/SU1296011A3/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/24Methods of sampling, or inoculating or spreading a sample; Methods of physically isolating an intact microorganisms
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/295Assays involving biological materials from specific organisms or of a specific nature from bacteria from Chlamydiales (o)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Description

6377863778

Menetelmä klamydian eristämiseksi Tämä keksintö koskee menetelmää klamydian eristämiseksi klamydiatartunnan diagnoosia varten, jossa menetelmässä kliininen näyte ympätään viljellyn solulinjan solui-5 hin, inkuboidaan ja muodostuneet inkluusiot detektoidaan sopivimmin valomikroskooppisesti värjäyksen jälkeen.The present invention relates to a method for isolating chlamydia for the diagnosis of chlamydial infection, in which a clinical sample is inoculated into cells of a cultured cell line, incubated and the resulting inclusions are preferably detected by light microscopy after staining.

Chlamydia trachomatis on prokaryootti organismi, joka tartuttaa eukaryoottisoluja ehdottomana solunsisäisenä loisena. Chlamydia trachomatis aiheuttaa ihmisessä useita sai-10 rauksia , ja tietoisuus sen merkityksestä kansanterveydelle on nopeasti kasvamassa (Paavonen, J. 1979. Chlamydial infections. Microbiological, diagnostic, and clinical aspects. Med.Biol. 54:135-151; Paavonen, J.,P.Saikku, E.Vesterinen, B.Meyer, E.Vartiainen, and E.Saksela. 1978.Chlamydia trachomatis is a prokaryotic organism that infects eukaryotic cells as an absolute intracellular parasite. Chlamydia trachomatis causes several diseases in humans, and awareness of its importance for public health is growing rapidly (Paavonen, J. 1979. Chlamydial infections. Microbiological, diagnostic, and clinical aspects. Med. Biol. 54: 135-151; Paavonen, J. , P.Saikku, E.Vesterinen, B.Meyer, E.Vartiainen, and E.Saksela 1978.

15 Genital chlamydial infections in patients attending a gynaecological outpatient clinic. Br. J.Vener. Dis. 54:257-261; Schachter, J. 1978. Chlamydial infections.15 Genital chlamydial infections in patients attending a gynecological outpatient Clinic. Br. J.Vener. Dis. 54: 257-261; Schachter, J. 1978. Chlamydial infections.

N. Engl.Med. 298:428-435, 490-495, 540-549; Taylor-Robinson, ' D., and B.J. Thomas. 1980. The role of Chlamydia trachomatis 20 in genital-tract and associated diseases.J. Clin. Pathol.N. Engl.Med. 298: 428-435, 490-495, 540-549; Taylor-Robinson, 'D., and B.J. Thomas. 1980. The role of Chlamydia trachomatis 20 in genital tract and associated diseases.J. Clin. Pathol.

33:205-235.) Klamydiatartuntojen laboratoriodiagnoosien varsinaisen läpimurron aiheutti kudosviljelymenetelmän kehittäminen organismin eristämistä varten säteilytetyissä McCoy soluissa (Gordon,F.B., H.R. Dressier, A.L. Quan, W.T.33: 205-235.) The actual breakthrough in laboratory diagnoses of chlamydial infections was caused by the development of a tissue culture method for isolating the organism in irradiated McCoy cells (Gordon, F.B., H.R. Dressier, A.L. Quan, W.T.

25 McQuilkin, and J.I. Thomas. 1972. Effect of ionizing radiation on susceptibility of McCoy cell cultures to Chlamydia trachomatis.Appi.Microbiol. 23:123-129; Gordon, F.B. and A.L.Quan. 1965. Isolation of the trachoma agent in cell culture.Proc. Soc. Biol.Med. 118: 354-359.) Alunperin käytet-30 ty McCoy solulinja on läheistä sukua hiiren fibroblastiselle syöpäsolulinjalle L929 (Blyth, W.A., and J. Taverene. 1972. Cultivation of TRIC agents: a comparison between the use of BHK-21 and irradiated McCoy cells. J.Hyg. 72:121-128).25 McQuilkin, and J.I. Thomas. 1972. Effect of ionizing radiation on the susceptibility of McCoy cell cultures to Chlamydia trachomatis.Appi.Microbiol. 23: 123-129; Gordon, F.B. and A.L.Quan. 1965. Isolation of the trachoma agent in cell culture.Proc. Soc. Biol.Med. 118: 354-359.) The McCoy cell line originally used is closely related to the mouse fibroblast cancer cell line L929 (Blyth, WA, and J. Taverene. 1972. Cultivation of TRIC agents: a comparison between the use of BHK-21 and irradiated McCoy cells. J. Hyg. 72: 121-128).

Paitsi McCoy solulinjan, myös monien muiden solulinjojen on 35 osoitettu olevan herkkiä klamydialle (Croy, T.R., C.C. Kuo, and S.P. Wang. 1975- Comparative suspectibility of eleven mammalian cell lines to infection with trachoma organisms.In addition to the McCoy cell line, many other cell lines have been shown to be susceptible to chlamydia (Croy, T.R., C.C. Kuo, and S.P. Wang. 1975- Comparative suspectibility of Eleven mammalian cell lines to infection with trachoma organisms.

2 63778 J.Clin. Microbiol. 1:434-439; Rota, T.R. 1977. Chlamydia trachomatis in cell culture. Susceptibility of seven established mammalian cell types in vitro. Adaption of ; trachoma organisms to McCoy and BHK-21 cells. In vitro ; 5 13:280-292.), mutta vain harvat ovat riittävän herkkiä ' käytettäviksi organismin eristämiseen kliinisistä näytteistä.2 63778 J.Clin. Microbiol. 1: 434-439; Rota, T.R. 1977. Chlamydia trachomatis in cell culture. Susceptibility of seven established mammalian cell types in vitro. Adaptation of; trachoma organisms to McCoy and BHK-21 cells. In vitro; 5 13: 280-292.), But few are sensitive enough to be used to isolate the organism from clinical specimens.

Sen lisäksi että kliininen näyte sentrifugoidaan solu-kerroksen päälle, solut tavallisesti esi- tai jälkikäsitel-10 lään niiden jakautumisen estämiseksi ja klamydian solunsisäi-sen jakautumisen lisäämiseksi. Säteilyyn liittyvät käytännön ongelmat ovat johtaneet vaihtoehtoisten menetelmien käyttöön solujen käsittelyssä.In addition to centrifuging the clinical specimen over the cell layer, the cells are usually pretreated or post-treated to prevent their proliferation and to increase the intracellular proliferation of chlamydia. Practical problems with radiation have led to the use of alternative methods in cell processing.

Säteilytyksen tai käsittelyn IUdR:llä, sytokalasiini , ! 15 B:llä tai sykloheksimidillä on ilmoitettu kasvattavan I |Irradiation or treatment with IUdR, cytocalazine,! 15 B or cycloheximide has been reported to increase I |

McCoy solujen herkkyyttä klamydialle. Jotkut tutkijat ovat j ! v väittäneet, että käsittelemättömät McCoy solut ovat yhtä j , herkkiä kuin säteilytetyt solut klamydian eristämiseen j ; (Hobson, D., F.W.A. Johnson, E. Rees, and I.A. Taita.1974. 1 ; 20 Simplified method for diagnosis of genital and occular infections with chlamydia. Lancet ii:555), mutta jotkut puolestaan ovat osoittaneet, että ne ovat vähemmän herkkiä ja inkluusioiden pienen koon vuoksi on vaikea todeta inkluusiot ja laskea ne (Evans, R.T. and D. Taylor-Robinson. 1979. ; ! 25 Comparison of various McCoy cell treatment procedures used ( : for detection of Chlamydia trachomatis. J. Clin. Microbiol. ! jMcCoy cell susceptibility to chlamydia. Some scientists are j! v argued that untreated McCoy cells are as j, sensitive as irradiated cells to isolate chlamydia j; (Hobson, D., FWA Johnson, E. Rees, and IA Taita.1974. 1; 20 Simplified method for diagnosis of genital and occular infections with Chlamydia. Lancet ii: 555), but some have shown that they are less sensitive and due to the small size of the inclusions, it is difficult to detect and count the inclusions (Evans, RT and D. Taylor-Robinson. 1979.;! 25 Comparison of various McCoy cell treatment procedures used (for detection of Chlamydia trachomatis. J. Clin. Microbiol .! j

* I* I

10; 198-201). Monet laboratoriot ovat havainneet säteilytyk- f 3en vaikeaksi toimenpiteeksi ja yrittävät välttyä hankkimas- ( ta kobolttilähdettä säteilytystarkoitukseen. Samoin kaikilla j 30 solujen aineenvaihdunnan estävillä ja sytotoksisilla yhdisteillä voi olla joitakin terveydellisiä riskivaikutuksia j laboratoriohenkilökuntaan.Erilaisten solulinjojen ja käsittelyjen käyttö osoittanee, että parasta tekniikkaa klamydian eristämiseksi ei ole vielä löydetty.10; 198-201). Radiation has been found by many laboratories to be a difficult procedure and attempts to avoid obtaining a source of cobalt for irradiation. not yet found.

55 Vaikka solujen sykloheksimidi-käsittelyä pidetäänkin laajalti herkimpänä menetelmänä, säteilytystä käytetään i •'delleen monissa laboratorioissa kasvattamaan solujen tar- , 3 63778 tuntaherkkyyttä.55 Although cycloheximide treatment of cells is widely considered to be the most sensitive method, irradiation is still used in many laboratories to increase the sensitivity of cells to 3 63778 hours.

Tämän keksinnön mukaiselle menetelmälle on pääasiallisesti tunnusomaista se, että näyte ympätään Mus musculus castaneous hiirilajin sikiön epiteelisoluista viljellyn 5 solulinjan soluihin.The method of the present invention is mainly characterized in that the sample is inoculated from fetal epithelial cells of Mus musculus castaneous into cells of a cultured 5 cell line.

Epiteelisolu on ihmisen klamydiatartunnan ensisijainen kohde. Koska ei-transformoituneita, puhtaita epiteeli-soluviljelmiä on vaikea saada aikaan, epiteelisolujen kokeellista tartuntaa on ollut vaikea suorittaa.Mus musculus 10 castaneous hiirilajien sikiöstä eristetyn pysyvän epiteeli-solulinjan, MMC-E:n viljelemisen onnistuminen (Rapp, U.R., J. Keski-Oja, and U.I. Heine. 1979- Establishment and characterization of the epithelial mouse embryo cell line MMC-E. Cancer Res. 39:^111-^113) ja solulinjan karakteri-15 sointi on tehnyt mahdolliseksi tutkia in vitro sellaisten tautien eri aspekteja, jotka yleensä saavat aikaan muutoksia epiteeliin.The epithelial cell is the primary target of human chlamydial infection. Because untransformed, pure epithelial cell cultures are difficult to obtain, experimental infection of epithelial cells has been difficult to perform. Successful culturing of a permanent epithelial cell line, MMC-E, isolated from the fetus of Musculus 10 castaneous mice (Rapp, UR, J. Central Oja, and UI Heine 1979- Establishment and characterization of the epithelial mouse embryo cell line MMC-E. Cancer Res. 39: ^ 111- ^ 113) and the characterization of the cell line character-15 have made it possible to study various aspects of such diseases in vitro, which usually cause changes in the epithelium.

MMC-E solulinja eristettiin alunperin Mus musculus castaneouksen sikiöstä ja luokiteltiin epiteliaaliseksi 20 morfologiansa perusteella. MMC-E viljelmässä nähdään tiiviitä liitoksia ja desmosomimaisia rakenteita tarkasteltaessa suurella suurennoksella. Immunofluoresenssissa nähdään pieniä määriä solupinnan fibronektiiniä ja lisäksi viljelmistä saadaan virustransformaatiolla huonosti differentoi-25 tuneita karsinoomia "nude-hiirissä”. Solut sisältävät myös keratiinirihmoja, jotka ovat epiteelisolujen erikoisominaisuus (Keski-Oja, J., Lehto, V.-P. and Virtanen I. 1981. Keratin filaments of cultured mouse epithelial cells are rapidly affected by epidermal qrowth factor. J.Cell Biol.The MMC-E cell line was originally isolated from the fetus of Mus musculus castaneous and classified as epithelial based on its morphology. In MMC-E culture, tight junctions and desmosome-like structures are seen when viewed at high magnification. Immunofluorescence shows small amounts of cell surface fibronectin, and in addition, cultures produce poorly differentiated carcinomas by viral transformation in “nude mice.” Cells also contain keratin strands, a special feature of epithelial cells (Keski-Oja, J., Lehto, V.-P. 1981. Keratin filaments of cultured mouse epithelial cells are rapidly affected by epidermal qrowth factor J. Cell Biol.

30 90:531-5^1). MMC-E solut eivät ole tuumorigeenisiä "nude- hiirissä" ja niissä ilmentyy "epidermal growth factorin'1 (EGP) reseptoreita suuria määriä. EGF voi stimuloida soluja jakautumaan sekä saa aikaan differentaatioita muistuttavia morfologisia muutoksia (Keski-Oja, J., I.U. Heine, U.R.30 90: 531-5 ^ 1). MMC-E cells are non-tumorigenic in "nude mice" and express high levels of epidermal growth factorin1 (EGP) receptors. EGF can stimulate cell division and induce differentiation-like morphological changes (Keski-Oja, J., IU Heine , UR

35 Rapp, and B. Wetzel. 19Ö0. Epidermal growth factor-induced alterations in proliferating mouse epithelial cells.Exp.35 Rapp, and B. Wetzel. 19Ö0. Epidermal growth factor-induced Alterations in proliferating mouse epithelial cells.Exp.

Cell Res. 128:279-290). "Murine sarcoma" kasvutekijät saa- 4 63778 vat aikaan viljelytilanteessa näissä soluissa transformoidun fenotyypin (Keski-Oja, J., J.E. DeLarco, U.R. Rapp, and G.J. Todaro. 1980. Murine sarcoma growth factors affect the growth and morphology of cultured mouse epithelial cells. ' 5 J.Cell Physiol. 104:41-46).Cell Res. 128: 279-290). "Murine sarcoma" growth factors produce a phenotype transformed in these cells in culture (Keski-Oja, J., JE DeLarco, UR Rapp, and GJ Todaro. 1980. Murine sarcoma growth factors affect the growth and morphology of cultured mouse epithelial cells .5 J. Cell Physiol. 104: 41-46).

Tässä yhteydessä tutkittiin näiden hiiren sikiön epiteelisolujen herkkyyttä Chlamydia trachomatikselle. Saatiin selville, että MMC-E soluviljelmät olivat herkkiä Chlamydia trachomatis tartunnalle ilman mitään käsittelyä, jos käy-10 tetään tiheitä, vanhoja viljelmiä, jolloin estetään solujen, mutta ei klamydian kasvua.In this context, the susceptibility of these mouse fetal epithelial cells to Chlamydia trachomatis was studied. It was found that MMC-E cell cultures were susceptible to Chlamydia trachomatis infection without any treatment if dense, old cultures were used, thereby inhibiting cell growth but not chlamydia growth.

Käsittelemätön Mus musculus castaneouksen sikiön epi-teelisolulinja MMC-E on yhtä herkkä Chlamydia trachomatis tartunnalle kuin standardi McCoy menetelmä, jossa käytetään 15 säteilytettyjä soluja, ja sillä on merkittäviä etuja sekä kliinisessä rutiinidiagnoosissa että in vitro epitee- ;; lisolujen kokeellista klamydiatartuntaa tutkittaessa.The untreated fetal Musculus castaneous fetal epithelial cell line MMC-E is as susceptible to Chlamydia trachomatis infection as the standard McCoy method using 15 irradiated cells and has significant advantages in both routine clinical diagnosis and in vitro epithelialization; when examining experimental chlamydial infection of cells.

MMC-E solut ovat herkkiä Chlamydia trachomatis tartunnalle ilman mitään esi- tai jälkikäsittelyä ja ovat verrat- ' 20 tavissa tavallisesti eristyksessä käytettyihin, säteilytet- i tyihin McCoy soluihin. Sykloheksimidillä käsitellyt MMC-E solut mahdollistavat yhä useammissa laboratorioissa klamy- » diatartuntojen rutiinidiagnoosit ja ovat hyödyllisiä in .MMC-E cells are susceptible to Chlamydia trachomatis infection without any pre- or post-treatment and are comparable to irradiated McCoy cells commonly used in isolation. Cycloheximide-treated MMC-E cells allow for the routine diagnosis of chlamydial infections in an increasing number of laboratories and are useful in.

vitro epiteelisolujen klamydiatartuntoihin liittyvien me-25 kanismien tutkimuksissa. i Käsittelemättömien MMC-E solujen käyttö klamydian .in vitro studies of the mechanisms involved in chlamydial infections of epithelial cells. i Use of untreated MMC-E cells for chlamydia.

eristämiseen on hyödyllistä klamydiatartuntojen rutiini- 1 ί diagnooseissa, ainakin sellaisissa laboratorioissa, joissa McCoy solujen esikäsittelyt ovat liian vaikeita suorittaa.isolation is useful in routine diagnoses of chlamydial infections, at least in laboratories where pretreatments of McCoy cells are too difficult to perform.

30 MMC-E solujen käyttö mahdollistaa täten klamydian eristä- mistestien suorittamisen yhä useammissa laboratorioissa.The use of MMC-E cells thus allows chlamydia isolation tests to be performed in an increasing number of laboratories.

Ceuraavassa selostetaan lähemmin erästä keksinnön sovellutusesimerkkiä. fAn embodiment of the invention will be described in more detail below. f

Colujen viljely 35 MMC-E solut kasvatettiin soluviljelyä varten käsitel- i lyissä muoviDulloissa (Tissue culture plastic petri dish) 5 63778 BHK-nesteessä, johon oli lisätty 10 % vasikan sikiön seerumia ja 50 pg/mg gentamysiiniä. Kantasolut irrotettiin tryosiini-EDTA:11a oasasointia varten viikoittain suhteessa 1:5- Noin 3 x 10 kpl soluja viljeltiin 1,0 ml:ssa 5 ravintonestettä tasapohjaisessa muoviputkessa, joka sisälsi pyöreän, halkaisijaltaan 13 mm:n, steriloidun peitinlasin, johon viljellyt solut tarttuivat. Putkia inkuboitiin 35°C:een lämmössä, 5 %:n hiilidioksidi-ilmastuksessa ja ne olivat valmiita näytteen ymppäykseen, pohjan täyttyessä soluista 10 1-2 päivää myöhemmin.Colon culture 35 MMC-E cells were grown in Tissue culture plastic Petri dish 5 63778 in BHK supplemented with 10% fetal calf serum and 50 pg / mg gentamicin. Stem cells were detached for weekly 1: 5 tryosin-EDTA for oasis staining. Approximately 3 x 10 cells were cultured in 1.0 ml of 5 medium in a flat-bottomed plastic tube containing a round, 13 mm diameter sterilized coverslip to which the cultured cells adhered. . The tubes were incubated at 35 ° C, 5% carbon dioxide aeration, and were ready for inoculation of the sample, with the bottom filling the cells 10 1-2 days later.

Säteilytetyt McCoy soluviljelmät valmistettiin samanlaisiin putkiin (ks. edellä) tavanomaisesti (Terho, P. 1978. Isolation techniques of Chlamydia trachomatis from patients with nonspecific urethritis. Dermatol. Monatsschr.Irradiated McCoy cell cultures were prepared in similar tubes (see above) conventionally (Terho, P. 1978. Isolation techniques of Chlamydia trachomatis from patients with nonspecific urethritis. Dermatol. Monatsschr.

15 164:515-520).15 164: 515-520).

C. trachomatis -kontrollikanta Käytetty kanta oli C.trachomatis serotyyppi L2 (434Bu), joka alkuaan on hankittu eräältä lontoolaiselta silmätauti-klinikalta. Se pasasoitiin laboratoriossa säteilytetyissä 20 McCoy soluissa kuten on kuvattu (Saikku, P., and J. Paavo-nen. 1978. Single-antigen immunofluorescence test for chlamydial antibodies. J. Clin. Microbiol. 8:119-121). Tämän kontrollikannan infektiviteetti oli 5 x 10^ inkluusiota muodostavaa yksikköä/ml määriteltynä säteilytetyissä McCoy 25 soluputkissa. 10-kertaiset kontrollikannan sarjalaimennok-set 0,2 M sakkaroosi - 0,02 M fosfaattiliuoksessa (2SP) (Gordon, P.B., and A.L. Quan. 1965· Isolation of the trachoma agent in cell culture. Proc.Soc.Biol.Med. 118:354-359),johon on lisätty 3 % vasikan sikiön seerumia, 50 /ag/ml gentamy-30 siiniä ja 25 U/ml nystatiinia, olivat juuri ennen käyttöä valmistettuj a.C. trachomatis control strain The strain used was C. trachomatis serotype L2 (434Bu), originally obtained from an ophthalmology clinic in London. It was passaged in laboratory irradiated McCoy cells as described (Saikku, P., and J. Paavonen. 1978. Single-antigen immunofluorescence test for chlamydial antibodies. J. Clin. Microbiol. 8: 119-121). The infectivity of this control strain was 5 x 10 6 inclusion units / ml as determined in irradiated McCoy 25 cell tubes. Serial 10-fold dilutions of control strain in 0.2 M sucrose-0.02 M phosphate solution (2SP) (Gordon, PB, and AL Quan. 1965 · Isolation of the trachoma agent in cell culture. Proc.Soc.Biol.Med. 118 : 354-359) supplemented with 3% fetal calf serum, 50 μg / ml gentamicin-30 and 25 U / ml nystatin were prepared just prior to use.

Kliiniset näytteetClinical specimens

Tutkimusmateriaalina käytettiin Helsingin yliopiston iho- ja sukupuolitautien poliklinikalla toukokuussa 1980 otet-35 tuja 110 virtsaputken ja kohdunsuunkaulan näytettä potilaista, joilla oli ei-gonokokkaalinen uretriitti tai kervisiitti.A total of 110 urethral and cervical samples from patients with non-gonococcal urethritis or cervicitis taken in May 1980 at the Outpatient Clinic of Dermatology and Venereology of the University of Helsinki were used as research material.

63778 663778 6

Ympin ja infektiivisyyden titraaminenInoculation and titration of infectivity

Kaikki ympit tehtiin kahtena rinnakkaisena sekä MMC-E että McCoy solulinjasta. 0,1 ml molempien solulinjojen kont-rollikantoja aplisoitiin putkiin, jotka sisälsivät konfluent-5 teja eli viljelyastian pohjan täyttäviä viljelmiä käsittelemättömiä MMC-E soluja tai säteilytettyjä McCoy soluja. 0,2 M sakkaroosi-0,02 M fosfaattipuskurilla inokuloituja soluja käytettiin negatiivisina kontrolleina.All inoculations were performed in duplicate from both the MMC-E and McCoy cell lines. 0.1 ml of control strains from both cell lines were applied to tubes containing confluent-5, i.e. cultures filling the bottom of the culture vessel, untreated MMC-E cells or irradiated McCoy cells. Cells inoculated with 0.2 M sucrose-0.02 M phosphate buffer were used as negative controls.

Kliiniset näytteet sulatettiin, jos ne olivat jäädytet-10 tyjä, ja homogenisoitiin sekoittamalla 20 sekunnin ajan.Clinical samples were thawed if frozen and homogenized by stirring for 20 seconds.

Näyte jaettiin kahteen samankokoiseen osaan (0,5 ml kumpikin) ja ympättiin soluviljelmiin.The sample was divided into two equal sized portions (0.5 ml each) and inoculated into cell cultures.

Näyte aplisoitiin sentrifugoimalla 3000 xg 1 tunnin ajan 35°C:eessa.Soluja inkuboitiin kaksi päivää 37°C:eessa.Jodi-15 värjäystä vartenravintoneste poistettiin putkesta ja lisättiin 1 ml metanolia ja annettiin seistä 10 minuuttia huoneen lämmössä. Metanoli poistettiin ja lisättiin 1 ml tavaramerkillä Lugol myytävää värjäysnestettä (valmistaja:Merck, Darmstadt) ja annettiin seistä 20 minuuttia huoneen lämmössä. 20 Värjäysneste poistettiin ja peitinlasi otettiin putkesta. Jodilla värjättyjen inkluusioiden laskeminen suoritettiin standarditekniikan mukaisesti mikroskoopissa (Paavonen, J.,M. Kousa, P. Saikku, E. Vesterinen, E. Jansson,and A. Lassus.1978. Examination of men with nongonococcal 25 urethritis and their sexual partners for Chlamydia trachomatis and Ureaplasma Urealyticum.Sex. Transm.Dis. 5:93-96).The sample was applied by centrifugation at 3000 xg for 1 hour at 35 ° C. The cells were incubated for two days at 37 ° C. For iodine-15 staining, the medium was removed from the tube and 1 ml of methanol was added and allowed to stand for 10 minutes at room temperature. The methanol was removed and 1 ml of Lugol dye (manufactured by Merck, Darmstadt) was added and allowed to stand for 20 minutes at room temperature. The staining liquid was removed and the coverslip was taken from the tube. Calculation of iodine-stained inclusions was performed according to standard techniques under a microscope (Paavonen, J., M. Kousa, P. Saikku, E. Vesterinen, E. Jansson, and A. Lassus.1978. Examination of men with nongonococcal 25 urethritis and their sexual partners for Chlamydia trachomatis and Ureaplasma Urealyticum.Sex. Transm.Dis. 5: 93-96).

Inkluusiot käsittelemättömissä MMC-E soluissa olivat kooltaan vastaavia kuin McCoy soluissa ja helppoja detektoida. Tällaisia käsittelemättömiä MMC-E soluja si-30 sältäviä eristysputkia voidaan valmistaa päivittäin.Inclusions in untreated MMC-E cells were similar in size to McCoy cells and easy to detect. Insulation tubes containing such untreated MMC-E cells can be prepared daily.

Täten vältytään ongelmalta laskea milloin säteilyttää solut ja viljellä niitä peitinlasilla monta päivää ennen näyt-, teen saamista. Esitelty menetelmä on heti käyttövalmis klamydian rutiiniviljelyyn. Jodivärjäys osoittautui sopivak-35 31 suurien näytemäärien seulontaan.This avoids the problem of calculating when to irradiate the cells and culturing them on a coverslip for many days before receiving the sample. The presented method is immediately ready for use in routine chlamydia culture. Iodine staining proved to be suitable for screening large volumes of samples.

Käsittelemättömien MMC-E solujen asemasta on mahdollista käyttää myös esim. sykloheksimidillä käsiteltyjä MMC-EInstead of untreated MMC-E cells, it is also possible to use e.g. MMC-E treated with cycloheximide.

FI814023A 1981-12-15 1981-12-15 FOERFARANDE FOER ISOLERING AV KLAMYDIA FI63778C (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
FI814023A FI63778C (en) 1981-12-15 1981-12-15 FOERFARANDE FOER ISOLERING AV KLAMYDIA
JP83500105A JPS58502083A (en) 1981-12-15 1982-12-15 How to isolate chlamydia
PCT/FI1982/000063 WO1983002122A1 (en) 1981-12-15 1982-12-15 Method for the isolation of chlamydia
EP19830900038 EP0097196A1 (en) 1981-12-15 1982-12-15 Method for the isolation of chlamydia
SU833637905A SU1296011A3 (en) 1981-12-15 1983-08-12 Method for isolation of chlamydia trachomatis

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI814023 1981-12-15
FI814023A FI63778C (en) 1981-12-15 1981-12-15 FOERFARANDE FOER ISOLERING AV KLAMYDIA

Publications (2)

Publication Number Publication Date
FI63778B true FI63778B (en) 1983-04-29
FI63778C FI63778C (en) 1983-08-10

Family

ID=8514957

Family Applications (1)

Application Number Title Priority Date Filing Date
FI814023A FI63778C (en) 1981-12-15 1981-12-15 FOERFARANDE FOER ISOLERING AV KLAMYDIA

Country Status (5)

Country Link
EP (1) EP0097196A1 (en)
JP (1) JPS58502083A (en)
FI (1) FI63778C (en)
SU (1) SU1296011A3 (en)
WO (1) WO1983002122A1 (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4118469A (en) * 1976-04-27 1978-10-03 Research Corporation Antigen for trachoma lymphogranuloma venereum (LGV) and non-gonococcal urethritis (NGU)
EP0017460A1 (en) * 1979-04-02 1980-10-15 Research Corporation Immunofluorescent test method and substance for use therein
US4427782A (en) * 1981-03-03 1984-01-24 Caldwell Harlan D Isolation of principal outer membrane protein and antigen of Chlamydia trachomatis

Also Published As

Publication number Publication date
EP0097196A1 (en) 1984-01-04
FI63778C (en) 1983-08-10
WO1983002122A1 (en) 1983-06-23
JPS58502083A (en) 1983-12-08
SU1296011A3 (en) 1987-03-07

Similar Documents

Publication Publication Date Title
Chernesky The laboratory diagnosis of Chlamydia trachomatis infections
Coleman et al. A prospective study of human polyomavirus infection in pregnancy
Yoder et al. Microtest procedure for isolation of Chlamydia trachomatis
Borchardt et al. A comparison of the sensitivity of the InPouch TV, Diamond's and Trichosel media for detection of Trichomonas vaginalis.
Ridgway et al. Current problems in microbiology: 1. Chlamydial infections: which laboratory test?
Grossmann et al. Progress on isolation and short-term ex-vivo culture of highly purified non-apoptotic human intestinal epithelial cells (IEC)
US5137030A (en) Diagnostic methods
FI63778C (en) FOERFARANDE FOER ISOLERING AV KLAMYDIA
Ripa Microbiological diagnosis of Chlamydia trachomatis infection
US6472206B1 (en) In situ growth, freezing and testing of cultured cells
Mondal et al. Isolation, identification and characterization of Salmonella from duck
Abro et al. Biochemical activities of bacterial species isolated from the frozen semen of cattle
RU2456616C2 (en) Instant diagnostic techqniue for mixed herpes viral and bacterial infections in children
Cantero et al. Maximizing the immunological output of the cervicovaginal explant model
Cavaliere et al. Cervico-vaginal Chlamydia trachomatis infection in pregnant adolescent and adult women: A morphologic and immunofluorescent study
WO2016079733A1 (en) Method for early diagnosis of cancer
Rota Techniques for culturing and determining antimicrobial susceptibility of Chlamydia trachomatis
Meštrović et al. Technical aspects of Chlamydia trachomatis antimicrobial susceptibility testing in cell culture system
RU2768491C1 (en) Method for diagnosing human papillomavirus by the concentration of molecular markers
Joseph et al. In vitro culture of various species of microsporidia causing keratitis: evaluation of three immortalized cell lines
RU2449277C2 (en) Method of predicting infection of newborn babies and puerperants
Keski-Oja et al. Isolation of Chlamydia trachomatis in Untreated MMC-E mouse epithelial cells
RU2401862C2 (en) Method of isolating enterococcus from fresh pathological material
CN219652972U (en) Chip and device for screening sperms without anti-sperm antibody
Abd El-Aal et al. Ocular Chlamydia trachomatis in a tertiary hospital

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: LABSYSTEMS OY